Repeat Cesarean Section

Subscribe to Selected New Research on Repeat Cesarean Section

68 relevant articles (1 outcomes, 5 trials/studies) found for this Therapy

Description: Extraction of the fetus by abdominal hysterotomy anytime following a previous cesarean.

Also Known As:

Cesarean Section, Repeat; Cesarean Sections, Repeat; Repeat Cesarean Sections; Section, Repeat Cesarean; Sections, Repeat Cesarean

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Obstetric Surgical Procedures: 56

Obstetric Delivery: 24

Cesarean Section: 8361

Repeat Cesarean Section: 68

Experts

1.	Myers, Stephen A: 1 article (09/2005)
2.	Bennett, Timothy L: 1 article (09/2005)
3.	Sato, Akira: 1 article (01/2004)
4.	Tanaka, Toshinobu: 1 article (01/2004)
5.	Yasuda, Kazuhito: 1 article (01/2004)
6.	Ogawa, Masaki: 1 article (01/2004)
7.	Hosoya, Naoko: 1 article (01/2004)
8.	Shimizu, Dai: 1 article (01/2004)
9.	Joura, E A: 1 article (03/2001)
10.	Husslein, P: 1 article (03/2001)

Related Diseases

1.	Hairy Cell Leukemia 05/01/1998 - "Repeat cesarean section at 38 weeks produced a 2875 gm healthy male infant with Apgar scores of 9 and 9. CONCLUSION: If antepartum management of hairy cell leukemia is warranted, splenectomy is a safe and effective treatment option during the second trimester." Get all the results and reference details, order at left...
2.	Infection 10/01/1997 - "STUDY DESIGN: Amniochorionic membranes were collected from women undergoing elective repeat cesarean section with no history of infection" 10/01/1997 - "STUDY DESIGN: Amniochorionic membranes were collected from women with documented intraamniotic infection and from women not in labor undergoing elective repeat cesarean section with no signs of infection or other complications of pregnancy" 06/01/1996 - "STUDY DESIGN: Amniochorionic membranes were collected from women undergoing elective repeat cesarean section and showing no signs of infection- or pregnancy-related complications" 08/01/1984 - "Infection was significantly more common among patients undergoing primary as compared with repeat cesarean section and was three times more frequent among patients with membranes ruptured for 12 hours or more compared with those with membranes ruptured less than 12 hours" 09/01/1976 - "In diminishing order, the incidence of infection was: cesarean section monitored, 90 of 223 (40.4 per cent); cesarean section not monitored, 56 of 271 (20.4 per cent); elective repeat cesarean section, 1 of 21 (5 per cent); vaginal delivery monitored, 33 of 1,236 (2.7 per cent); and vaginal delivery not monitored, 49 of 3,445 (1.4 per cent)" Get all the results and reference details, order at left...
3.	Cephalopelvic Disproportion 06/01/1986 - "The main indication for cesarean section in the study group was cephalopelvic disproportion, while in the control group it was repeat cesarean section" 06/01/1998 - "Efforts to lower cesarean section rates of individual practitioners should focus on the areas of fetal distress, cephalopelvic disproportion, and repeat cesarean section." 08/01/1996 - "MATERIALS AND METHODS: Ga levels were measured by RIA in maternal serum, amniotic fluid and cord sera of newborns in 55 cases with the following conditions: normal pregnancy and eutocic vaginal delivery (n = 8), repeat cesarean section (n = 10), and cardiotogographic register suggestive of fetal compromise (n = 15), cephalopelvic disproportion (n = 8), preeclampsia (n = 7) and postdate pregnancy (n = 7)" 03/01/1985 - "Analysis of the data showed major differences in indications for cesarean section in the areas of repeat cesarean section, cephalopelvic disproportion, breech presentation, fetal distress, and genital herpes" Get all the results and reference details, order at left...
4.	Uterine Inertia 08/01/1972 - "The expected causes of death due to delay in giving adequate amounts of blood and fibrinogen occurred in this series but the most striking results of this study were the findings of (1) a large number of cases of placenta acreta in patients with repeat cesarean sections and (2) the lack of manual exploration of the uterus in many patients dying from uterine atony." Get all the results and reference details, order at left...
5.	Uterine Rupture 11/01/1986 - "The incidence of symptomatic uterine rupture was higher in patients scheduled for repeat cesarean section than for patients who underwent a trial of labor" 01/01/1984 - "Patients with previous cesarean section generally are subjected to repeat cesarean section for fear of uterine rupture and its subsequent catastrophic complications" 01/15/1981 - "The rationale for routine repeat cesarean section (RCS) is avoidance of uterine rupture during labor" 11/01/1979 - "There were no uterine ruptures on vaginal exploration after delivery or at the time of repeat cesarean section during labor" 04/01/1998 - "Although the rates of uterine rupture and neonatal asphyxia were slightly higher in women who attempted a VBAC than in women who underwent an elective cesarean section, obstetricians should offer the option of a trial of labor, because more than one-half of the women with a previous cesarean delivery might have successful vaginal deliveries, and the VBAC-related maternal mortality rate does not reportedly differ between women undergoing a trial of labor and women undergoing an elective repeat cesarean section." Get all the results and reference details, order at left...
45 Diseases and 68 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Fibrinogen (Factor I)
2.	Misoprostol (Cytotec)
3.	Lutein
4.	Oxytocin (Pitocin)
5.	Gases
6.	Ephedrine
6 Drugs and Important Bio-Agents and 5 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Splenectomy
2.	Cesarean Section (Caesarean Section)
3.	Hysterectomy
4.	Epidural Analgesia
5.	Spinal Anesthesia
11 Therapies and Procedures and 28 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>